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Abstract 
Background: Several systematic reviews have investigated pancreatic stump management to reduce 
the postoperative pancreatic fistula (POPF) rate. The study aimed to evaluate if the parenchymal 
transection using the triple-row reinforced stapler decreases the incidence of POPF compared with 
ultrasonic transection after distal pancreatectomy (DP). 
 
Methods: a bicentric, phase 3, patient-blinded, randomized clinical trial was conducted. All patients  
submitted to elective DP from July 2018 through July 2020 were screened. Exclusion criteria were 
an extended resection, gastrointestinal resections or anastomoses, and a pancreatic thickness >17 mm 
measured at the point of parenchymal transection. The experimental group received the Endo GIA 
Reinforced Reload with Tri-Staple TechnologyÒ (TS), while the control group the Harmonic Focus® 
(US).  
 
Results: A total of 152 patients undergoing DP met the inclusion criteria and were randomized. Due 
to a positive transection margin on frozen section analysis requiring further resection, seven patients 
were excluded post-randomization. Therefore, the final population comprised 72 patients in the TS 
arm and 73 patients in the US arm. Overall, 23 patients (16%) developed POPF. There were 19 grade 
B (14%) and 4 grade C fistulas (2%). The incidence of POPF was similar between groups (TS 12% 
vs. US 19%, p=0.191). 
Conclusion: the present randomized controlled trial of stapled transection using a PGA-reinforced 
triple-row stapler versus ultrasonic transection with HARMONICÒ energy devices in elective DP 
demonstrated no significant difference in POPF rates. 
Introduction 
In the largest series analyzing risk factors for postoperative pancreatic fistula (POPF) following distal 
pancreatectomy (DP), several perioperative variables were identified (1). Yet, most of the research 
endeavors have been focused on the pancreatic transection method, a modifiable factor with the 
potential for improving the fistula rates (2). Several techniques have been proposed, including sharp 
transection with handsewn closure (using mattress sutures or fish-mouth stitches), stapled transection, 
transection with energy-based devices (diathermy, ultrasonic devices, with or without ligation of the 
main pancreatic duct), or even anastomosis of the pancreatic stump to a Roux-en-Y jejunal limb or 
as a pancreaticogastrostomy (3–7). Furthermore, the use of additional biologic sealants or stump 
reinforcement with an omental or falciform ligament patch have been investigated with mixed results 
(8,9). Remarkably, none of these techniques have demonstrated a clear superiority over the others in 
randomized controlled trials (10,11). Over the last decade, stapler and energy-based devices have 
been increasingly adopted because of the more frequent use of minimally invasive approaches and 
because of the easy, fast, and reproducible mechanism of action. Recently a new type of triple-row 
staplers reinforced with a preloaded bioabsorbable polyglycolic acid (PGA) felt has been marketed, 
with preliminary data showing a decrease in the incidence and severity of POPF compared with the 
standard stapler and with ultrasonic devices, provided a pancreatic thickness <17 mm (12–14). In a 
recent retrospective, propensity-score matched analysis of 184 patients we suggested that the use of 
a triple-row reinforced stapler was associated with a marked reduction of POPF rates relative to the 
ultrasonic dissector group (12% versus 40%) (15). Under these premises, we sought to evaluate 
whether, in elective DP, parenchymal transection using the triple-row reinforced stapler decreases the 





Study design and participants 
This study is a bicentric, phase 3, patient-blinded, randomized clinical trial conducted from July 2018 
through July 2020 at the Unit of General and Pancreatic Surgery, University of Verona Hospital Trust, 
Verona, Italy; and the Unit of Pancreatic Surgery, Ospedale Pederzoli, Peschiera del Garda, Italy. 
The study protocol was approved by the Ethics Committee of the Provinces of Verona and Rovigo 
(#1664CESC) and registered at ClinicalTrial.gov (NCT03880773). The trial was performed in 
accordance with the good clinical practice guidelines, the principles of the Declaration of Helsinki, 
and the Consolidated Standards of Reporting Trials (CONSORT) Guidelines (16).  Patients between 
the ages of 18 and 80 with any indication for elective DP were eligible for inclusion. All eligible 
patients provided written informed consent at the time of hospital admission. The CONSORT 
flowchart is reported in Figure 1.  
 
Randomization and masking 
The randomization process was as follows: on intraoperative exploration, patients were excluded if 
an extended DP was needed. This involved a posterior RAMPS for left adrenal/kidney infiltration or 
a synchronous arterial resection (celiac trunk or hepatic artery) or an associated bowel resection. 
Synchronous venous resection was not an exclusion criterion. In eligible patients, pancreatic 
thickness was measured at the point of parenchymal transection via intraoperative ultrasound. Only 
patients with a parenchymal thickness <17 mm were enrolled in the trial and randomized by telephone 
in a 1:1 ratio using a computer-generated randomization list kept by independent data managers at 
the coordinating center (Unit of General and Pancreatic Surgery, University of Verona Hospital Trust) 
and concealed to the investigators. Patients were blinded to the arm allocation during the 
postoperative course. The 17-mm cutoff was used to avoid staple closure failure or parenchymal 
crushing, according to previous evidences (12,17). Post-randomization drop-out occurred in the 
instance of positive transection margin on frozen section analysis, requiring and extension of the 
resection up to total pancreatectomy.   
 
Procedures 
DP were performed by specialized pancreatic surgeons who completed the learning curve and had a 
personal annual caseload exceeding 50 major pancreatic resections. All surgeons were familiar with 
both of the stump management techniques used in this trial. DP was performed either via laparotomy 
or minimally invasive approaches (laparoscopic or robot-assisted), with or without spleen 
preservation (18–20). The level of pancreatic transection at the neck, body, or tail, depended on the 
nature and the location of the lesion. Stapled transection was performed using an Endo GIA 
Reinforced Reload with Tri-Staple TechnologyÒ (COVIDIEN, North Haven, CT, USA). Either a 
purple (3 mm) or black (4 mm) cartridge was employed according to the single surgeon’s preference. 
A gradual compression was applied for 2-3 minutes, the stapler was then fired and slowly released 
after transection. Ultrasonic transection was performed using the Harmonic Focus®+ Shears (open 
surgery) or the Harmonic Ace®+ Shears (minimally invasive surgery), HARMONIC, Johnson & 
Johnson Medical, Ethicon, Tokyo, Japan. Ultrasonic technology uses high-frequency mechanical 
energy that cuts by cavitational fragmentation and simultaneously seals tissues by coaptive 
coagulation (21). The pancreas was transected at the lowest vibration level, no additional sutures were 
placed into the pancreatic stump or the main pancreatic duct. In both arms an easy-flow drain was 
placed in the proximity of pancreatic stump. Postoperative drain management was described 
elsewhere and was standardized across the participating institutions (22).  
 
Outcomes 
The primary endpoint was the incidence of POPF as defined by the International Study Group of 
Pancreatic Surgery (23). Secondary endpoints were any complications, classified according to the 
Clavien-Dindo score (24), major complications, defined as Clavien-Dindo grade III or higher, 
delayed gastric emptying (DGE) and post-pancreatectomy hemorrhage (PPH), classified according 
to the International Study Group on Pancreatic Surgery definitions (25,26), postoperative hospital 
stay (including readmission), and 90-day mortality. Follow-up visits were carried out at 30 and 90 
days from the index operation, including cross-sectional imaging (computed tomography or magnetic 
resonance) serum tumor markers, glycemia, platelet count and physical examination. 
 
Statistical Analysis 
The study was designed hypothesizing that stapled transection was superior to ultrasonic transection. 
The sample size was calculated based on previously published institutional retrospective data 
reporting a 40% and 12% POPF rates following ultrasonic and stapled transection, respectively (15). 
Assuming a 20.5% delta in the prospective trial, at a 5% alpha and 80% power (1-beta), the required 
sample size was 138 patients (69 per arm) according to the continuity corrected Z-Test with unpooled 
variance. Adjustment for post-randomization drop-out was made expecting a 10% rate of transection 
margin positivity on frozen section analysis, leading to a total sample size of 152 patients (76 per 
arm). Demographic and clinical characteristics were age, gender, American Society of 
Anesthesiologists (ASA) score, body mass index (BMI, kg/m2) categorized based on WHO 
classification (27), diabetes mellitus, age-adjusted Charlson comorbidity index score (28), chronic 
steroid therapy, neoadjuvant chemotherapy. Surgical variables included operative approach, 
conversion from minimally invasive to open approach, splenectomy, pancreatic gland thickness 
measured by intraoperative ultrasound at the point of transection, transection level categorized into 
gastroduodenal artery level, pancreatic neck, and left border of the aorta or more distal, vascular 
venous resection, intraoperative blood loss (mL), and operating time (minutes). In the stapled 
transection arm, the compression ratio (defined as the pancreas thickness divided by the closed length 
of the stapler), and the height difference (defined as the difference between the pancreatic thickness 
and the closed length of the stapler) were calculated (12,29). The values of closed length were defined 
per the manufacturer specifications. 
Continuous variables were expressed as means with standard deviation or medians with interquartile 
range (IQR) and compared using t-test or Mann-Whitney test, as appropriate. Categorical variables 
were expressed as absolute numbers and percentages and compared using chi-square test or Fisher’s 
exact test. All tests were two-tailed. Binary logistic regression analysis was performed to investigate 
factors associated with POPF. Factors with a p-value <0.1 on univariable screening were entered in 
the model. Data are presented with odds ratios and 95% confidence intervals. A p-value <0.05 was 
considered statistically significant. Data were analyzed using the Statistical Package for the Social 




A total of 152 patients undergoing DP met the inclusion criteria and were randomized (Figure 2). Due 
to a positive transection margin on frozen section analysis requiring further resection, seven patients 
were excluded post-randomization. Therefore, the final population comprised 72 patients in the 
stapled transection arm and 73 patients in the ultrasonic transection arm. The baseline characteristics 
per randomization arm are outlined in Table 1. The median pancreatic thickness measured 
intraoperatively at the transection level was 12 mm in both groups. 
 
Primary endpoint 
Overall, 23 patients (16%) developed POPF (Table 2). There were 19 grade B (14%) and 4 grade C 
fistulas (2%). The incidence of POPF was similar between groups (12% in stapled transection versus 
19% in ultrasonic dissection, p=0.191). Biochemical leak (BL) occurred in 42 patients (29%), 21 
patients in each arm (p=0.552). 
 
Secondary endpoints 
Table 2 shows the postoperative outcomes. In all, 57 patients (39%) had any complication, without 
differences between groups (35% in stapled transection versus 44% in ultrasonic transection, 
p=0.170). There was an increased incidence of abdominal collections in the ultrasonic dissection 
group (32% versus 14%, p=0.009). Five patients (3%) underwent reoperation, mostly for a 
hemorrhage (three of five patients). There was one postoperative death in the ultrasonic dissection 
group. This patient died on postoperative day four of an aortic dissection, that was confirmed on 
autopsy.  The median length of stay was similar between groups (8 days, p=0.880).  
Sub-analysis of risk factors for POPF is shown in Table 3. POPF was associated with a higher median 
BMI, pancreas transection level, and intraoperative blood transfusion. In the stapled transection 
group, the compression rate and the height difference were not correlated with POPF (p=0.362 and 
p=0.979, respectively). Intraoperative blood transfusion was the only independent risk factors for 
POPF (OR 4.8, 95% CI 1.2-20, p=0.032) on logistic regression analysis (Table 4).  
 
Discussion 
The present randomized clinical trial of stapled versus ultrasonic transection in DP demonstrated no 
significant difference in POPF rates. Analysis of secondary outcomes revealed a greater incidence of 
abdominal collections in the ultrasonic dissection arm. POPF therefore remains a clinically relevant 
and unsolved issue for patients undergoing elective DP, with a formation process likely independent 
on the surgical technique adopted for resection and closure of the pancreatic remnant. Our findings 
indeed resonate with previously published randomized controlled trials, that did not identify an 
optimal transection method able to decrease POPF in DP (30).  
To the best of our knowledge, this is the first randomized trial of a triple-row stapler reinforced with 
a preloaded PGA felt. Previous studies had already shown that wrapping the pancreatic stump with a 
PGA mesh decreased the rate of POPF (31,32), and triple-row stapler had been associated with less 
POPF compared with the double-row staplers (33). The Endo GIA Reinforced Reload with Tri-Staple 
TechnologyÒ has been available at the authors’ institution since its introduction into the market and 
has been employed at the surgeon’s discretion for parenchymal transection in DP. A retrospective 
propensity-matched analysis comparing surgical outcomes with ultrasonic dissection 
(HARMONICÒ Focus or Ace) suggested a significantly decreased rate of POPF in the reinforced 
Tri-Staple group (12% versus 40%), constituting the backbone for the present trial. As suggested by 
earlier studies, patients with a parenchymal thickness > 17 mm were excluded because of a very high 
incidence of POPF that was independent on the type of cartridge (12). In patients who were 
randomized to stapled transection we gradually compressed the pancreas with the stapler for about 2-
3 minutes, then divided the parenchyma and released the device slowly. This has been shown to help 
avoiding the development of POPF (34). Nonetheless, the choice of the stapler cartridge was left at 
the single surgeon’s discretion. While cartridges with closed length <15 mm (i.e. purple) have been 
shown to be particularly suitable for thin pancreata (<12 mm), in thicker glands a longer staple height 
has been recommended (i.e. black) although no particular cartridge has proven to outperform the 
others.   
In the ultrasonic dissection arm, the pancreas was transected and simultaneously sealed by coaptive 
coagulation at the lowest vibration level. Several experimental studies proved that the lateral thermal 
spread is limited to 0-2 mm beyond the tissue grasped within the forceps of the device (35). The 
decreased propensity for collateral thermal damage is an important putative advantage of the 
Harmonic scalpel, particularly when compared with other energy devices such as monopolar and 
bipolar diathermy, which are commonly used for pancreatic transection in DP (30). However, a 
correlation between ultrasonic transection and POPF healing has been suggested by our group, in that 
ultrasonic transection resulted independently associated with a slower fistula healing (36). Whether 
this depends on thermal damage has to be fully elucidated.  
Analysis of factors associated with POPF suggest that BMI and the anatomic transection level play 
an integral role to the process. BMI is indeed a surrogate of fatty infiltration, that has been shown to 
correlate with a complicated clinical course (26,33,34). Even the transection level has been widely 
reported as a predictor of POPF, because the pancreas thickness is anatomically different at the 
gastroduodenal artery level, at the neck, or in the body and tail (8,11). Nonetheless, only 
intraoperative blood transfusion was an independent risk factor on multivariable analysis. This is in 
accordance with a recent systematic review and meta-analysis and might be a surrogate parameter for 
pancreatic stump ischemia (38). Taken together, these results emphasize the need for perioperative 
composite scores to predict high-risk scenarios and help establishing individualized prevention and 
mitigation strategies. While these tools have been derived and successfully validated in 
pancreatoduodenectomy (39), previous efforts in large, multi-institutional DP series have proven 
elusive (40).    
The study has some limitations. First, sub-analysis of stapler cartridges was not done. The liberal use 
of purple or black cartridge with PGA reinforcement possibly introduced a bias. However, the 
compression rate and the height difference were not associated with POPF. Another limitation could 
be the difference in the anatomic point of parenchymal transection, that was indeed associated with 
POPF. Nonetheless, the point of transection was dictated by the underlying pathology, with 
parenchyma-sparing procedures being favored in the context of benign to low-grade neoplasms. 
Indeed, this parameter did not result to be a risk factor at the adjusted analysis.  
 
Conclusion 
The present randomized controlled trial of stapled transection using a PGA-reinforced triple-row 
stapler versus ultrasonic transection with HARMONICÒ energy devices in elective DP demonstrated 
no significant difference in POPF rates and no substantial impact on other secondary endpoints. The 
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Table 1. Demographic, Intraoperative, and Pathological data 
 










Age (years, IQR) 60 [50-70] 62 [50-70] 60 [50-69] 
Gender (Female) 87 (60%) 48 (67%) 39 (53%) 
BMI (Kg/m2, IQR) 25 [22-27] 24 [21-27] 25 [22-28] 
Diabetes 24 (17%) 13 (18%) 11 (15%) 
ASA score ³ III 18 (12%) 8 (11%) 10 (14%) 
Charlson Age >4 48 (33%) 25 (35%) 23 (32%) 
Neoadjuvant therapy 31 (21%) 15 (21%) 16 (22%) 
Minimally invasive 59 (41%) 29 (40%) 30 (41%) 
Conversion# 2 (3%) 0 (0%) 2 (7%) 
Spleen preserving 14 (17%) 10 (14%) 14 (19%) 
Vascular resection 4 (3%) 0 (0%) 4 (6%) 
Transection level    
Pancreatic neck 104 (72%) 50 (69%) 54 (74%) 
GDA level 3 (2%) 3 (4%) 0 (0%) 
Left aortic border 38 (26%) 19 (26%) 19 (26%) 
IOUS thickness (mm, IQR) 12 [10-14] 12 [10-14] 12 [10-15] 
Duration of Surgery 
(minutes, IQR) 251 [201-334] 246 [201-321] 257 [202-335] 
EBL (cc, IQR) 100 [50-300] 100 [100-300] 150 [50-300] 
Blood transfusion 11 (8%) 4 (6%) 7 (10%) 
Pathology, No. (%)    
PDAC 54 (37%) 32 (44%) 22 (30%) 
pNET 39 (27%) 17 (24%) 22 (30%) 
IPMN 8 (6%) 4 (6%) 4 (6%) 
MCN/SCN 30 (20%) 16 (22%) 14 (19%) 
SPT 6 (4%) 2 (3%) 4 (6%) 
Other 8 (6%) 1 (1%) 7 (9%) 
# Referred to minimally-invasive procedures 
BMI: body mass index; ASA: American society of Anesthesiology; GDA: 
gastroduodenal artery; IOUS: intraoperative ultrasound; EBL: estimated blood loss; 
PDAC: pancreatic ductal adenocarcinoma; pNET: pancreatic neuroendocrine tumor; 
IPMN: intraductal papillary mucinous neoplasm; MCN: mucinous cystic neoplasm; 



































Table 2. Postoperative outcomes 
 











Any complication 57 (39%) 25 (35%) 32 (44%) 0.170 
POPF 23 (16%) 9 (12%) 14 (19%) 0.191 
Grade B 19 (14%) 8 (12%) 11 (16%)  
Grade C 4 (2%) 1 (1%) 3 (4%)  
Biochemical leak 42 (29%) 21 (29%) 21 (29%) 0.552 
Abdominal collection 33 (23%) 10 (14%) 23 (32%) 0.009 
DGE 4 (3%) 3 (4%) 1 (1%) 0.305 
PPH 11 (8%) 3 (4%) 8 (11%) 0.109 
ICU Admission 17 (12%) 7 (9%) 10 (13%) 0.314 
Clavien-Dindo ³ 3 19 (13%) 6 (8%) 13 (18%) 0.074 
Length of Stay  
(days, IQR) 
8 [6-13] 8 [6-13] 8 [6-12] 0.880 
Reoperation 5 (3%) 2 (3%) 3 (4%) 0.507 
Readmission 14 (10%) 4 (6%) 10 (14%) 0.083 
Mortality 1 (1%) 0 (0%) 1 (1%) 0.500 
POPF: postoperative pancreatic fistula; DGE: delayed gastric empty; PPH: Post pancreatectomy 













Table 3. Univariable analysis of factors associated with POPF 
 







Age (years, IQR) 62 [55-71] 60 [50-69] 0.564 
Sex (Female) 11 (48%) 76 (62%) 0.143 
BMI (Kg/m2, IQR) 26 [25-29] 24 [21-27] 0.013 
Diabetes 2 (9%) 22 (18%) 0.218 
ASA score ³ III 3 (13%) 15 (12%) 0.573 
Charlson Age >4 8 (35%) 40 (33%) 0.514 
Neoadjuvant therapy 5 (22%) 26 (21%) 0.577 
Minimally invasive 12 (52%) 47 (39%) 0.161 
Spleen preserving 4 (17%) 20 (16%) 0.555 
Vascular resection 1 (4%) 3 (3%) 0.503 
Transection level   0.040 
Pancreatic neck 14 (13%) 90 (87%)  
GDA level 2 (67%) 1 (33%)  
Left aortic border 7 (18%) 31 (82%)  
IOUS thickness (mm, IQR) 13 [11-15] 12 [10-14] 0.307 
Compression Rate# (mm, SD) 3,5 ± 0,5 3,4 ± 0,6 0.362 
Height Difference# (mm, SD) 8,3 ± 1,8 8,3 ± 2,2 0.979 
Duration of Surgery (minutes, IQR) 293 [216-378] 246 [201-321] 0.126 
EBL (cc, IQR) 200 [75-300] 100 [50-300] 0.399 
Blood transfusion 5 (22%) 6 (5%) 0.016 
Pathology PDAC 10 (19%) 13 (14%) 0.326 
# related only to the TS group patients 
BMI: body mass index; ASA: American society of Anesthesiology; GDA: gastroduodenal 
















































Table 4. Multivariable analysis of factors associated with POPF 
 
Study Population N° = 145 
 POPF P value OR (CI 95%) 
BMI (Kg/m2)    
<24,9 Kg/m2 7 (10%) 1 \ 
25-29,9 Kg/m2 11 (20%) 0.209 1.9 (0.6 - 5.8) 
>30 Kg/m2 5 (29%) 0.924 1 (0.4 – 2.3) 
Transection level    
Pancreatic neck 14 (13%) 1 \ 
GDA level 2 (67%) 0.357 1.4 (0.6 – 3.4) 
Left aortic border 7 (18%) 0.114 0.2 (0.3 – 1.5) 
Blood transfusion 5 (46%) 0.032 4.8 (1.2 - 20) 
    
BMI: body mass index; GDA: gastroduodenal artery; POPF: postoperative pancreatic 
fistula. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
